Symptom profiles in children with advanced cancer

Patient, family caregiver, and oncologist ratings

Donna S. Zhukovsky, Cathy L. Rozmus, Rhonda S. Robert, Eduardo Bruera, Robert J. Wells, Gary B. Chisholm, Julio A. Allo, Marlene Z. Cohen

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

BACKGROUND Systematic symptom assessment is not routinely performed in pediatric oncology. The objectives of the current study were to characterize the symptoms of pediatric oncology outpatients and evaluate agreement between patient and proxy reports and the association between children's ratings and oncologists' treatment recommendations. METHODS Two versions of the pediatric Memorial Symptom Assessment Scale (pMSAS) were translated into Spanish. An age-appropriate and language-appropriate pMSAS was administered independently before visits to the oncologist to patients and family caregivers (caregivers) and after visits to consenting oncologists. Statistical analysis included Spearman correlation coefficients and weighted kappa values. RESULTS English and Spanish results were similar and were combined. A total of 60 children and their caregivers completed the pMSAS. The children had a median age of 10 years (range, 7-18 years); approximately 62% were male and 33% were Spanish-speaking. Fourteen oncologists completed the pMSAS for 25 patients. Nine patients (15%) had no symptoms and 38 patients (63%) reported ≥2 symptoms. The most common symptoms were fatigue (12 patients; 40%) and itch (9 patients; 30%) for the younger children and pain (15 patients; 50%) and lack of energy (13 patients; 45%) among the older children. Total and subscale score agreement varied by proxy type and subscale, ranging from fair to good for most comparisons. Agreement for individual symptoms between the patient and proxy ranged from a kappa of -0.30 (95% confidence interval, -0.43 to -0.01) to 0.91 (95% confidence interval, 0.75 to 1.00). Three of 51 symptomatic patients (6%) had treatment recommendations documented in the electronic health record. CONCLUSIONS Symptoms are common and cross several functional domains. Proxy and child reports are often not congruent, possibly explaining apparent undertreatment among this group of patients. Cancer 2015;121:4080-4087.

Original languageEnglish (US)
Pages (from-to)4080-4087
Number of pages8
JournalCancer
Volume121
Issue number22
DOIs
StatePublished - Nov 1 2015

Fingerprint

Caregivers
Symptom Assessment
Neoplasms
Proxy
Pediatrics
Oncologists
Confidence Intervals
Electronic Health Records
Fatigue
Outpatients
Language

Keywords

  • caregiver
  • child
  • neoplasm
  • patient experience
  • symptoms

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Zhukovsky, D. S., Rozmus, C. L., Robert, R. S., Bruera, E., Wells, R. J., Chisholm, G. B., ... Cohen, M. Z. (2015). Symptom profiles in children with advanced cancer: Patient, family caregiver, and oncologist ratings. Cancer, 121(22), 4080-4087. https://doi.org/10.1002/cncr.29597

Symptom profiles in children with advanced cancer : Patient, family caregiver, and oncologist ratings. / Zhukovsky, Donna S.; Rozmus, Cathy L.; Robert, Rhonda S.; Bruera, Eduardo; Wells, Robert J.; Chisholm, Gary B.; Allo, Julio A.; Cohen, Marlene Z.

In: Cancer, Vol. 121, No. 22, 01.11.2015, p. 4080-4087.

Research output: Contribution to journalArticle

Zhukovsky, DS, Rozmus, CL, Robert, RS, Bruera, E, Wells, RJ, Chisholm, GB, Allo, JA & Cohen, MZ 2015, 'Symptom profiles in children with advanced cancer: Patient, family caregiver, and oncologist ratings', Cancer, vol. 121, no. 22, pp. 4080-4087. https://doi.org/10.1002/cncr.29597
Zhukovsky DS, Rozmus CL, Robert RS, Bruera E, Wells RJ, Chisholm GB et al. Symptom profiles in children with advanced cancer: Patient, family caregiver, and oncologist ratings. Cancer. 2015 Nov 1;121(22):4080-4087. https://doi.org/10.1002/cncr.29597
Zhukovsky, Donna S. ; Rozmus, Cathy L. ; Robert, Rhonda S. ; Bruera, Eduardo ; Wells, Robert J. ; Chisholm, Gary B. ; Allo, Julio A. ; Cohen, Marlene Z. / Symptom profiles in children with advanced cancer : Patient, family caregiver, and oncologist ratings. In: Cancer. 2015 ; Vol. 121, No. 22. pp. 4080-4087.
@article{b30bcd22c9384cfa8f2eb250b81254f7,
title = "Symptom profiles in children with advanced cancer: Patient, family caregiver, and oncologist ratings",
abstract = "BACKGROUND Systematic symptom assessment is not routinely performed in pediatric oncology. The objectives of the current study were to characterize the symptoms of pediatric oncology outpatients and evaluate agreement between patient and proxy reports and the association between children's ratings and oncologists' treatment recommendations. METHODS Two versions of the pediatric Memorial Symptom Assessment Scale (pMSAS) were translated into Spanish. An age-appropriate and language-appropriate pMSAS was administered independently before visits to the oncologist to patients and family caregivers (caregivers) and after visits to consenting oncologists. Statistical analysis included Spearman correlation coefficients and weighted kappa values. RESULTS English and Spanish results were similar and were combined. A total of 60 children and their caregivers completed the pMSAS. The children had a median age of 10 years (range, 7-18 years); approximately 62{\%} were male and 33{\%} were Spanish-speaking. Fourteen oncologists completed the pMSAS for 25 patients. Nine patients (15{\%}) had no symptoms and 38 patients (63{\%}) reported ≥2 symptoms. The most common symptoms were fatigue (12 patients; 40{\%}) and itch (9 patients; 30{\%}) for the younger children and pain (15 patients; 50{\%}) and lack of energy (13 patients; 45{\%}) among the older children. Total and subscale score agreement varied by proxy type and subscale, ranging from fair to good for most comparisons. Agreement for individual symptoms between the patient and proxy ranged from a kappa of -0.30 (95{\%} confidence interval, -0.43 to -0.01) to 0.91 (95{\%} confidence interval, 0.75 to 1.00). Three of 51 symptomatic patients (6{\%}) had treatment recommendations documented in the electronic health record. CONCLUSIONS Symptoms are common and cross several functional domains. Proxy and child reports are often not congruent, possibly explaining apparent undertreatment among this group of patients. Cancer 2015;121:4080-4087.",
keywords = "caregiver, child, neoplasm, patient experience, symptoms",
author = "Zhukovsky, {Donna S.} and Rozmus, {Cathy L.} and Robert, {Rhonda S.} and Eduardo Bruera and Wells, {Robert J.} and Chisholm, {Gary B.} and Allo, {Julio A.} and Cohen, {Marlene Z.}",
year = "2015",
month = "11",
day = "1",
doi = "10.1002/cncr.29597",
language = "English (US)",
volume = "121",
pages = "4080--4087",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "22",

}

TY - JOUR

T1 - Symptom profiles in children with advanced cancer

T2 - Patient, family caregiver, and oncologist ratings

AU - Zhukovsky, Donna S.

AU - Rozmus, Cathy L.

AU - Robert, Rhonda S.

AU - Bruera, Eduardo

AU - Wells, Robert J.

AU - Chisholm, Gary B.

AU - Allo, Julio A.

AU - Cohen, Marlene Z.

PY - 2015/11/1

Y1 - 2015/11/1

N2 - BACKGROUND Systematic symptom assessment is not routinely performed in pediatric oncology. The objectives of the current study were to characterize the symptoms of pediatric oncology outpatients and evaluate agreement between patient and proxy reports and the association between children's ratings and oncologists' treatment recommendations. METHODS Two versions of the pediatric Memorial Symptom Assessment Scale (pMSAS) were translated into Spanish. An age-appropriate and language-appropriate pMSAS was administered independently before visits to the oncologist to patients and family caregivers (caregivers) and after visits to consenting oncologists. Statistical analysis included Spearman correlation coefficients and weighted kappa values. RESULTS English and Spanish results were similar and were combined. A total of 60 children and their caregivers completed the pMSAS. The children had a median age of 10 years (range, 7-18 years); approximately 62% were male and 33% were Spanish-speaking. Fourteen oncologists completed the pMSAS for 25 patients. Nine patients (15%) had no symptoms and 38 patients (63%) reported ≥2 symptoms. The most common symptoms were fatigue (12 patients; 40%) and itch (9 patients; 30%) for the younger children and pain (15 patients; 50%) and lack of energy (13 patients; 45%) among the older children. Total and subscale score agreement varied by proxy type and subscale, ranging from fair to good for most comparisons. Agreement for individual symptoms between the patient and proxy ranged from a kappa of -0.30 (95% confidence interval, -0.43 to -0.01) to 0.91 (95% confidence interval, 0.75 to 1.00). Three of 51 symptomatic patients (6%) had treatment recommendations documented in the electronic health record. CONCLUSIONS Symptoms are common and cross several functional domains. Proxy and child reports are often not congruent, possibly explaining apparent undertreatment among this group of patients. Cancer 2015;121:4080-4087.

AB - BACKGROUND Systematic symptom assessment is not routinely performed in pediatric oncology. The objectives of the current study were to characterize the symptoms of pediatric oncology outpatients and evaluate agreement between patient and proxy reports and the association between children's ratings and oncologists' treatment recommendations. METHODS Two versions of the pediatric Memorial Symptom Assessment Scale (pMSAS) were translated into Spanish. An age-appropriate and language-appropriate pMSAS was administered independently before visits to the oncologist to patients and family caregivers (caregivers) and after visits to consenting oncologists. Statistical analysis included Spearman correlation coefficients and weighted kappa values. RESULTS English and Spanish results were similar and were combined. A total of 60 children and their caregivers completed the pMSAS. The children had a median age of 10 years (range, 7-18 years); approximately 62% were male and 33% were Spanish-speaking. Fourteen oncologists completed the pMSAS for 25 patients. Nine patients (15%) had no symptoms and 38 patients (63%) reported ≥2 symptoms. The most common symptoms were fatigue (12 patients; 40%) and itch (9 patients; 30%) for the younger children and pain (15 patients; 50%) and lack of energy (13 patients; 45%) among the older children. Total and subscale score agreement varied by proxy type and subscale, ranging from fair to good for most comparisons. Agreement for individual symptoms between the patient and proxy ranged from a kappa of -0.30 (95% confidence interval, -0.43 to -0.01) to 0.91 (95% confidence interval, 0.75 to 1.00). Three of 51 symptomatic patients (6%) had treatment recommendations documented in the electronic health record. CONCLUSIONS Symptoms are common and cross several functional domains. Proxy and child reports are often not congruent, possibly explaining apparent undertreatment among this group of patients. Cancer 2015;121:4080-4087.

KW - caregiver

KW - child

KW - neoplasm

KW - patient experience

KW - symptoms

UR - http://www.scopus.com/inward/record.url?scp=84946500302&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84946500302&partnerID=8YFLogxK

U2 - 10.1002/cncr.29597

DO - 10.1002/cncr.29597

M3 - Article

VL - 121

SP - 4080

EP - 4087

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 22

ER -